- Nachrichtendetail
-
24.04.2024 02:29:48 - dpa-AFX: *EUROPEAN COMMISSION APPROVES ASTELLAS' XTANDI FOR RECURRENT EARLY PROSTATE CANCER TREATMENT EXPANSION
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTELLAS PHARMA INC. | 856273 | Frankfurt | 8,942 | 24.05.24 21:49:17 | +0,040 | +0,45% | 0,000 | 0,000 | 8,912 | 8,942 |
